88 related articles for article (PubMed ID: 2468865)
1. Serotonin metabolism and platelet aggregation under antihypertensive treatment with nitrendipine.
Sebeková K; Raucinová M; Sedláková K; Dzúrik R
J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S161-3. PubMed ID: 2468865
[TBL] [Abstract][Full Text] [Related]
2. [Effects of lotensin and nitrendipine on plasma fibrinogen and platelet aggregation in hypertensive patients].
Pan R; Sun M; Zhou H; Jia Z
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):87-9. PubMed ID: 10681808
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive effects of trandolapril and nitrendipine in the elderly: a controlled trial with special emphasis on time effect profiles.
Zannad F; Vaur L; Dutrey-Dupagne C; Genes N; Clerson P
J Hum Hypertens; 1996 Jan; 10(1):51-5. PubMed ID: 8642191
[TBL] [Abstract][Full Text] [Related]
4. Serotonin and platelet activation during treatment with isradipine.
Fetkovska N; Sebekova K; Fedelesova V; Dzurik R
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S31-3. PubMed ID: 1720482
[TBL] [Abstract][Full Text] [Related]
5. Acute effect of urapidil on peripheral serotonin metabolism.
Sebeková K; Fedelesová V; Blazícek P; Dzúrik R
Cor Vasa; 1990; 32(4):274-81. PubMed ID: 2225876
[TBL] [Abstract][Full Text] [Related]
6. Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin.
Amstein R; Fetkovska N; Pletscher A; Bühler FR
J Hypertens; 1989 Apr; 7(4):255-60. PubMed ID: 2723427
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hypertension with dihydropyridine calcium antagonists and aspirin.
Tison P; Ulicna L; Jakubovska Z; Oravcova J; Fetkovska N
Blood Press Suppl; 1994; 1():57-60. PubMed ID: 8205303
[TBL] [Abstract][Full Text] [Related]
8. Effect of nitrendipine in mild or moderate essential hypertensive subjects with type II diabetes.
Papalia D; Casale P
J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S98-100. PubMed ID: 1723469
[TBL] [Abstract][Full Text] [Related]
9. Effects of cilazapril and nitrendipine on blood pressure, mood, sleep, and cognitive function in elderly hypertensive patients: an Italian multicenter study.
Leonetti G; Salvetti A
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S73-7. PubMed ID: 7700071
[TBL] [Abstract][Full Text] [Related]
10. Hypercholesterolemia modulates the effects of nitrendipine on blood pressure and platelet function in essential hypertension.
Mazeaud MM; Sang KH; Astarie C; Levenson J; Simon A; Devynck MA
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S46-51. PubMed ID: 1725003
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study.
Arneklo-Nobin B; Elmér O; Akesson A
Int Angiol; 1988; 7(1):19-25. PubMed ID: 3290356
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
[TBL] [Abstract][Full Text] [Related]
14. Anti-hypertensive treatment with magnesium-aspartate-dichloride and its influence on peripheral serotonin metabolism in man: a subacute study.
Sebeková K; Revúsová V; Polakovicová D; Drahosová J; Zverková D; Dzúrik R
Cor Vasa; 1992; 34(5-6):390-401. PubMed ID: 1285056
[TBL] [Abstract][Full Text] [Related]
15. Saluretic and diuretic effects of antihypertensive nitrendipine monotherapy in man.
Sambhi MP
Angiology; 1988 Jan; 39(1 Pt 2):106-12. PubMed ID: 3341609
[TBL] [Abstract][Full Text] [Related]
16. Dual effect of nitrate therapy for cyclosporine-induced hypertension on vascular and platelet morphofunctional markers; an animal model.
Reis F; Teixeira de Lemos E; Almeida L; Parada B; Garrido AP; Rocha-Pereira P; Santos-Silva A; Santos-Dias J; Dinis A; Figueiredo A; Costa-Almeida C; Mota A; Teixeira F
Transplant Proc; 2007 Oct; 39(8):2501-6. PubMed ID: 17954158
[TBL] [Abstract][Full Text] [Related]
17. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
[TBL] [Abstract][Full Text] [Related]
18. Modulation of serotonergic and adrenergic systems by long-term antihypertensive treatment with enalapril.
Sebeková K; Jurecková K; Raucinová M; Balazovjech I; Dzúrik R
Cor Vasa; 1991; 33(3):206-17. PubMed ID: 1717198
[TBL] [Abstract][Full Text] [Related]
19. Hypercholesterolaemia alters platelet reactivity and the antihypertensive effect of nitrendipine.
Le Quan Sang KH; Mazeaud M; Levenson J; Del Pino M; Pithois-Merli I; Simon A; Devynck MA
J Hypertens Suppl; 1991 Dec; 9(6):S410-1. PubMed ID: 1668012
[No Abstract] [Full Text] [Related]
20. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]